TABLE 1.

Patient characteristics of uncomplicated P. vivax malaria treated by 3 days of chloroquine administration in French Guiana from 2009 to 2015^a

Parameter	Result for:			P
	Total	ACPR on D28	Recurrent parasitemia on D28
Patients, no. (%)
Total	172	164	8
By yr				0.554
2009	38 (22.1)	37 (97.4)	1 (2.6)
2010	37 (21.5)	35 (94.6)	2 (5.4)
2011	24 (14.0)	24 (100.0)	0 (0.0)
2012	44 (25.6)	41 (93.2)	3 (6.8)
2013	11 (6.4)	10 (90.9)	1 (9.1)
2014	8 (4.6)	7 (87.5)	1 (12.5)
2015	10 (5.8)	10 (100.0)	0 (0.0)
Gender, no. (%)				0.768
M/F ratio	2.37	2.35	3.00
Male	121 (70.4)	115 (95.0)	6 (5.0)
Female	51 (29.7)	49 (96.1)	2 (3.9)
Age, median yr (range)	33.00 (5–76)	33.00 (5–76)	30.50 (17–56)	0.134
Age group, no. (%)				0.496
Adults	163 (94.8)	155 (95.1)	8 (4.9)
5–15 yr old	9 (5.2)	9 (100.0)	0 (0.0)
History of malaria, no. (%)				<0.001*
Yes	56 (32.5)	55 (98.2)	1 (1.8)
No	93 (54.1)	91 (97.8)	2 (2.2)
Unknown	23 (13.4)	18 (78.3)	5 (21.7)
Prophylaxis, no. (%)				0.121
Yes	18 (10.5)	18 (100.0)	0 (0.0)
No	116 (67.4)	112 (96.6)	4 (3.4)
Unknown	38 (22.1)	34 (89.5)	4 (10.5)
Days before consultation, median no. (range)	3 (0–15)	3 (0–15)	1 (0–7)	0.428
Body wt, median kg (range)	72 (49–158)	72 (49–158)	68 (58–83)	0.493
Body temp, median °C (range)	39.0 (37.7–40.9)	39.0 (37.7–40.9)	38.9 (37.5–39.6)	0.672
Vomiting, no. (%)				0.671
Yes	59 (34.3)	57 (96.6)	2 (3.4)
No	106 (61.6)	100 (94.3)	6 (5.7)
Unknown	7 (4.1)	7 (100.0)	0 (0.0)
Parasitemia, median % infected blood cells (range)	0.15 (0.01–2.00)	0.15 (0.01–2.00)	0.13 (0.02–0.76)	0.218
Hospitalization, no. (%)				0.946
Yes	23 (13.4)	22 (95.7)	1 (4.3)
No	98 (57.0)	93 (94.9)	5 (5.1)
Unknown	51 (29.6)	49 (96.1)	2 (3.9)

^aACPR, adequate clinical and parasitological response; D28, day 28. *, P < 0.05 (significant difference).